Applications of Anti-Platelet Monitoring in Catheterization Laboratory

作者: Debabrata Mukherjee , David J. Moliterno

DOI: 10.1023/A:1018724827741

关键词:

摘要: Platelet function tests may measure different aspects of platelet function, which include adherence, activation, aggregation and secretion. The goal testing in the catheterization lab is to provide information about contributions risk thrombotic or hemorrhagic events optimization anti-platelet therapy for percutaneous interventions (PCI). Important clinical questions prior coronary are whether an antiplatelet agent having desired effect on inhibition (ef~cacy) patient has suf~cient residual avoid bleeding (safety). role aspirin thienopyridines well established management artery disease setting interventions. last several years have demonstrated unequivocal ef~cacy intravenously administered GPIIb/IIIa antagonists acute syndromes Twenty-~ve ago, important insight into molecular basis was provided by discovery that two major membrane glycoprotein bands, GPII GPIII were missing from surface thrombasthenic platelets [1]. To date, more than 60,000 patients with ischemic heart been treated trials a new class potent highly effective agents, speci~cally targeting this IIb/IIIa receptor [2]. Three such drugs licensed US Food Drug Administration, many phase II III potentially expanding series indications. Four parenterally (abciximab, epti~batide, tiro~ban lami~ban) tested indications, syndromes. show drug effect, all agents reducing events.

参考文章(43)
B.S. Coller, K.T. Springer, L.E. Scudder, J.L. Kutok, M Ceruso, G.D. Prestwich, Substituting isoserine for serine in the thrombin receptor activation peptide SFLLRN confers resistance to aminopeptidase M-induced cleavage and inactivation. Journal of Biological Chemistry. ,vol. 268, pp. 20741- 20743 ,(1993) , 10.1016/S0021-9258(19)36844-9
CL Wagner, MA Mascelli, DS Neblock, HF Weisman, BS Coller, RE Jordan, Analysis of GPIIb/IIIa Receptor Number by Quantification of 7E3 Binding to Human Platelets Blood. ,vol. 88, pp. 907- 914 ,(1996) , 10.1182/BLOOD.V88.3.907.907
Andreas Ruf, Franz-Josef Neumann, Gisela Pogátsa-Murray, Timm Dickfeld, Dietlind Zohlnhöfer, Albert Schömig, Meinrad Gawaz, Effect of Glycoprotein IIb-IIIa Receptor Antagonism on Platelet Membrane Glycoproteins after Coronary Stent Placement Thrombosis and Haemostasis. ,vol. 80, pp. 994- 1001 ,(1998) , 10.1055/S-0037-1615400
H K Gold, L W Gimple, T Yasuda, R C Leinbach, W Werner, R Holt, R Jordan, H Berger, D Collen, B S Coller, Pharmacodynamic study of F(ab')2 fragments of murine monoclonal antibody 7E3 directed against human platelet glycoprotein IIb/IIIa in patients with unstable angina pectoris. Journal of Clinical Investigation. ,vol. 86, pp. 651- 659 ,(1990) , 10.1172/JCI114757
Nancy S. Nicholson, Susan G. Panzer-Knodle, Neal F. Haas, Beatrice B. Taite, James A. Szalony, Jimmy D. Page, Larry P. Feigen, David M. Lansky, Anita K. Salyers, Assessment of platelet function assays American Heart Journal. ,vol. 135, pp. S170- S178 ,(1998) , 10.1016/S0002-8703(98)70245-5
Neal S. Kleiman, Albert E. Raizner, Robert Jordan, Ann L. Wang, Daniel Norton, Kenneth F. Mace, Alaknanda Joshi, Barry S. Coller, Harlan F. Weisman, Differential inhibition of platelet aggregation induced by adenosine diphosphate or a thrombin receptor-activating peptide in patients treated with bolus chimeric 7E3 Fab: Implications for inhibition of the internal pool of GPIIb/IIIa receptors Journal of the American College of Cardiology. ,vol. 26, pp. 1665- 1671 ,(1995) , 10.1016/0735-1097(95)00391-6
Maarten L Simoons, M Jan de Boer, MJ van Den Brand, AJ Van Miltenburg, JC Hoorntje, Guy R Heyndrickx, L Ron van der Wieken, D De Bono, Wolfgang Rutsch, Thomas F Schaible, None, Randomized trial of a GPIIb/IIIa platelet receptor blocker in refractory unstable angina. European Cooperative Study Group. Circulation. ,vol. 89, pp. 596- 603 ,(1994) , 10.1161/01.CIR.89.2.596
A. T. Nurden, J. P. Caen, An abnormal platelet glycoprotein pattern in three cases of Glanzmann's thrombasthenia. British Journal of Haematology. ,vol. 28, pp. 253- 260 ,(1974) , 10.1111/J.1365-2141.1974.TB06660.X
Robert A. Harrington, Neal S. Kleiman, Kandice Kottke-Marchant, A.Michael Lincoff, James E. Tcheng, Kristina N. Sigmon, Diane Joseph, Gaddiel Rios, Kathleen Trainor, Dale Rose, Charles S. Greenberg, Michael M. Kitt, Eric J. Topol, Robert M. Califf, Immediate and reversible platelet inhibition after intravenous administration of a peptide glycoprotein IIb/IIIa inhibitor during percutaneous coronary intervention American Journal of Cardiology. ,vol. 76, pp. 1222- 1227 ,(1995) , 10.1016/S0002-9149(99)80345-2